![]() |
市場調查報告書
商品編碼
2044473
個人化膳食補充品市場預測至2034年-按成分類型、劑型、個人化方法、應用、最終用戶、通路和地區分類的全球分析Personalized Supplements Market Forecasts to 2034 - Global Analysis By Ingredient Type, Dosage Form, Personalization Approach, Application, End User, Distribution Channel, and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球個人化營養補充劑市場規模將達到 124 億美元,並在預測期內以 14.7% 的複合年成長率成長,到 2034 年將達到 374 億美元。
個人化營養補充品是根據個人獨特的生化成分、基因譜、生活方式因素和特定健康目標量身定做的營養配方。與傳統的標準化綜合維他命不同,這些客製化產品利用DNA檢測、血液生物標記、腸道菌群分析和穿戴式技術的數據,精確地確定營養素的組合。這個市場代表醫療保健從被動應對向主動健康管理的根本性轉變,透過專門設計的補充劑,幫助消費者解決營養不足問題,最佳化健康狀況,滿足其生理需求和個人目標。
消費者對客製化健康解決方案的需求日益成長
現代消費者越來越傾向於選擇能夠反映自身獨特生理狀況和生活方式的個人化方案,而非通用型保健品。消費者基因檢測服務的普及使得個人生物數據的取得更加便捷,也提高了人們對自身營養需求和營養不足的認知,而這些需求和不足是通用型保健品無法充分解決的。隨著健康文化和預防性醫療策略的興起,人們的關注點已從治療疾病轉向最佳化健康,而個人化保健品正被視為實現這一目標的有效工具。個人化營養正變得越來越主流,社群媒體上的意見領袖和健康部落客分享了他們使用客製化方案的正面體驗,這使得即使是以前不了解保健品的人群也開始接受個人化方案。
個人化營養補充計劃高成本
對於一般消費者而言,全面的檢測和定製配方服務仍然價格高昂,高昂的價格嚴重限制了市場准入。基因分析、生物標記評估以及與營養專家的持續諮詢,其成本遠高於市面上常見的標準膳食補充劑。小批量生產定製配方需要專門的生產能力,而大規模生產的維生素品牌無法享受規模經濟效益,這進一步推高了價格。保險公司很少將這些服務視為預防性健康管理工具,而是將其視為醫療必需品,因此所有費用都由個人消費者承擔。這種成本障礙實際上將市場限制在富裕人群中,使其難以惠及大眾。
與穿戴式健康科技的整合
來自健身追蹤器、智慧型手錶和連網健康設備的持續數據流為營養補充劑的動態個人化提供了前所未有的機會。穿戴式裝置能夠監測睡眠模式、活動量、心率變異性和其他生理指標,提供遠超靜態基因檢測的即時洞察,從而實現配方的持續調整。開發能夠將穿戴式裝置數據轉化為具體營養建議的演算法的公司,可以提供基於訂閱的營養補充品服務,並根據消費者不斷變化的健康狀況進行調整。這種整合將個人化營養補充品從偶爾購買轉變為持續的健康夥伴關係,在提升客戶終身價值的同時,提供真正適應性強的營養,以滿足日常體力需求和恢復需求的波動。
監管方面的不確定性和安全性問題
全球個人化營養產品法規結構缺乏一致性,為市場參與企業帶來了巨大的合規挑戰和潛在的法律責任風險。與安全性已確立的標準化膳食補充劑不同,定製配方缺乏監管機構在做出市場核准決定時所依賴的廣泛測試歷史。小批量生產的品管、原料來源的檢驗以及針對特定患者的產品的標籤規範等問題都引發了人們的擔憂。儘管主要市場的監管機構仍在不斷完善針對個人化營養的監管框架,但這種不確定性阻礙了投資和業務擴張。此外,即使是涉及消費者安全的個別事件,也可能引發更嚴格的監管,進而對市場格局產生不利影響。
新冠疫情大大加速了個人化營養補充品的普及,消費者對免疫健康和整體健康韌性的關注度顯著提升。疫情封鎖期間,人們有時間自我反思,並將健康放在首位。許多人在家中進行檢測套組,並在遠距辦公的同時探索客製化營養方案。疫情對大眾市場營養補充品價值鏈的衝擊,凸顯了擁有專屬生產線、直接面對消費者的個人化服務的價值。此外,疫情也使遠端醫療諮詢和遠距健康監測變得司空見慣,消除了人們獲取專業營養指導的障礙。這些行為改變具有持久性,疫情後的消費者依然對個人化健康解決方案保持濃厚興趣,並期待便捷的居家檢測和線上營養配方服務。
在預測期內,維生素細分市場預計將佔據最大的市場佔有率。
預計在預測期內,維生素領域將佔據最大的市場佔有率。這反映了維生素在人類營養中的基礎性作用以及消費者對維生素的廣泛認知。在透過基因和生物標記檢測發現的營養缺乏症中,維生素缺乏症仍然是最常見的,尤其是維生素D、維生素B12和葉酸缺乏症,通常需要補充。個人化維生素配方可以根據個人的吸收率、影響代謝的基因變異以及日照和飲食限制等生活方式因素進行精確的劑量調整。大量支持補充維生素的臨床研究為這個新興成分類別提供了目前所缺乏的可信度,從而在整個預測期內提升了醫療保健專業人員的推薦度以及消費者對以維生素為中心的個人化治療方案的信心。
在預測期內,軟糖細分市場預計將呈現最高的複合年成長率。
在預測期內,軟糖產品預計將呈現最高的成長率,這主要得益於消費者對更便捷、更愉悅的服用方式的偏好,而非傳統的片劑和膠囊。個人化軟糖補充劑與軟糖維生素一同發展壯大,不僅深受不願吞嚥大藥片的年輕一代的喜愛,也吸引了尋求更易服用選擇的老年消費者。製造商克服了傳統軟糖產品中熱敏成分穩定性方面的挑戰,成功生產出口味和口感俱佳、營養功效顯著的個人化軟糖。此外,軟糖的形狀、顏色和口味均可客製化,進一步提升了個性化體驗,使每日服用補充劑不再是負擔,而成為一種享受,從而推動了軟糖產品在各個年齡段人群中的快速普及。
在預測期內,北美預計將佔據最大的市場佔有率,這得益於較高的健康意識、先進的D2C(直接面對消費者)檢測基礎設施以及有利於D2C業務的監管環境。該地區擁有眾多開創性的個人化營養補充品品牌,這些品牌與消費者建立了牢固的關係,並不斷提升其定製配方生產能力。基因檢測服務(包括祖源分析和健康篩檢)的普及,使消費者熟悉了可用於營養個人化的個人生物數據概念。強大的電子商務物流和訂閱服務的建立正在推動主導該市場的D2C經營模式的發展。醫療保健專業人員對輔助健康療法的接受度進一步凸顯了個人化營養補充品在尋求實證健康最佳化的北美消費者中的有效性。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於可支配收入的成長、健康意識的提高以及傳統醫學融入市場的機會。中國、印度和東南亞國家中產階級的快速成長表明,消費者越來越願意投資於預防醫學和健康產品。包括阿育吠陀和傳統中醫在內的傳統醫學體系,在概念上與個人化醫療方法相契合,並因此擁有了一群樂於接受個人化醫療的消費者群體。政府大力推動數位健康基礎設施和預防醫學框架的建設,正在推動個人化醫療所需的檢測和數據收集。該地區龐大的人口基數,加上目前相對較低的市場滲透率,蘊藏著巨大的成長潛力,因為當地企業正在開發價格適中、個人化的營養補充劑解決方案,以滿足當地消費者的偏好和價格敏感度。
According to Stratistics MRC, the Global Personalized Supplements Market is accounted for $12.4 billion in 2026 and is expected to reach $37.4 billion by 2034 growing at a CAGR of 14.7% during the forecast period. Personalized supplements are customized nutritional formulations tailored to an individual's unique biochemical makeup, genetic profile, lifestyle factors, and specific health goals. Unlike traditional one-size-fits-all multivitamins, these bespoke products utilize data from DNA testing, blood biomarkers, gut microbiome analysis, and wearable technology to deliver precise nutrient combinations. The market represents a fundamental shift from reactive healthcare to proactive wellness management, empowering consumers to address deficiencies and optimize health through supplementation designed specifically for their biological needs and personal objectives.
Growing consumer demand for customized health solutions
Modern consumers are increasingly rejecting generic health products in favor of tailored approaches that acknowledge their unique biological and lifestyle circumstances. Direct-to-consumer genetic testing services have democratized access to personal biological data, creating awareness of individual nutritional needs and deficiencies that generic supplements cannot adequately address. The rise of wellness culture and preventive health strategies has shifted focus from treating illness to optimizing well-being, with personalized supplements positioned as sophisticated tools for this purpose. Social media influencers and health bloggers amplifying their positive experiences with customized regimens further normalizes personalized nutrition, driving mainstream adoption across demographic segments previously unfamiliar with supplementation.
High cost of personalized supplement programs
Premium pricing structures significantly limit market accessibility as comprehensive testing and custom formulation services remain expensive propositions for average consumers. Genetic analysis, biomarker assessments, and ongoing consultations with nutrition professionals add substantial costs beyond standard off-the-shelf supplement products. Manufacturing small-batch, customized formulations requires specialized production capabilities that lack the economies of scale enjoyed by mass-produced vitamin brands, further elevating price points. Insurance providers rarely cover these services as preventive wellness tools rather than medical necessities, placing the full financial burden on individual consumers. This cost barrier effectively segments the market toward affluent demographics, restricting broader population penetration.
Integration with wearable health technology
Continuous data streams from fitness trackers, smartwatches, and connected health devices create unprecedented opportunities for dynamic supplement personalization. Wearables monitoring sleep patterns, activity levels, heart rate variability, and other physiological metrics provide real-time insights that can inform ongoing formulation adjustments far beyond static genetic testing. Companies developing algorithms that translate wearable data into actionable nutrient recommendations can offer subscription-based supplement services that evolve with changing consumer health status. This integration transforms personalized supplements from occasional purchases into continuous wellness partnerships, increasing customer lifetime value while delivering genuinely adaptive nutrition that responds to daily fluctuations in physical demands and recovery needs.
Regulatory uncertainty and safety concerns
Inconsistent global regulatory frameworks for personalized nutrition products create significant compliance challenges and potential liability risks for market participants. Unlike standardized supplements with established safety profiles, customized formulations lack the extensive testing history that regulators rely upon for market approval decisions. Questions arise regarding quality control for small-batch manufacturing, ingredient sourcing verification, and appropriate labeling for patient-specific products. Regulatory authorities in major markets continue developing frameworks specific to personalized nutrition, creating uncertainty that discourages investment and expansion. Additionally, consumer safety incidents-even isolated-could trigger restrictive regulations that reshape the entire market landscape unfavorably.
The COVID-19 pandemic dramatically accelerated personalized supplement adoption as consumers intensified focus on immune health and overall wellness resilience. Lockdown periods provided time for self-reflection and health prioritization, with many individuals completing at-home testing kits and exploring customized nutrition while working remotely. Supply chain disruptions affecting mass-market supplements highlighted the value of direct-to-consumer personalized services with dedicated production lines. The pandemic also normalized telehealth consultations and remote health monitoring, removing barriers to professional nutritional guidance. These behavioral changes proved durable, with post-pandemic consumers maintaining heightened engagement with personalized health solutions and expecting the convenience of at-home testing and online formulation services.
The Vitamins segment is expected to be the largest during the forecast period
The Vitamins segment is expected to account for the largest market share during the forecast period, reflecting their foundational role in human nutrition and widespread consumer familiarity. Vitamin deficiencies remain the most common nutritional gaps identified through genetic and biomarker testing, with Vitamin D, B12, and folate deficiencies frequently requiring correction through supplementation. Personalized vitamin formulations allow precise dosing adjustments based on individual absorption rates, genetic variants affecting metabolism, and lifestyle factors such as sun exposure and dietary restrictions. The extensive body of clinical research supporting vitamin supplementation provides credibility that newer ingredient categories lack, encouraging healthcare provider recommendations and consumer confidence in vitamin-focused personalized regimens throughout the forecast period.
The Gummies segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Gummies segment is predicted to witness the highest growth rate, driven by consumer preferences for enjoyable, convenient dosage formats over traditional pills and capsules. Personalized gummy supplements appeal strongly to younger demographics who grew up with gummy vitamins and resist swallowing large tablets, while also attracting older consumers seeking more palatable options. Manufacturers have overcome previous challenges with heat-sensitive ingredient stability, enabling personalized gummy production that maintains nutrient efficacy while delivering appealing flavors and textures. The ability to create customized gummy shapes, colors, and flavor combinations further enhances the personalized experience, making daily supplementation feel like a treat rather than a chore, driving rapid adoption across multiple age segments.
During the forecast period, the North America region is expected to hold the largest market share, supported by high health awareness, advanced direct-to-consumer testing infrastructure, and favorable direct-to-consumer business regulations. The region hosts numerous pioneering personalized supplement brands that have established strong consumer relationships and refined manufacturing capabilities for custom formulations. Widespread adoption of genetic testing services, including ancestry and health screening, has familiarized consumers with personal biological data concepts applicable to nutritional personalization. Robust e-commerce logistics and subscription service acceptance facilitate direct-to-consumer business models dominating this market. Healthcare practitioner openness to complementary wellness approaches further validates personalized supplementation among North American consumers seeking evidence-based health optimization.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rising disposable incomes, increasing health consciousness, and traditional medicine integration opportunities. Rapidly expanding middle classes in China, India, and Southeast Asian countries demonstrate growing willingness to invest in preventive health and wellness products. Traditional medicine systems including Ayurveda and Traditional Chinese Medicine provide philosophical alignment with personalized approaches, creating receptive consumer bases. Government initiatives promoting digital health infrastructure and preventive care frameworks support testing and data collection essential for personalization. The region's large population base, combined with relatively low current market penetration, presents substantial growth potential as local players develop affordable personalized supplement solutions appropriate for regional preferences and price sensitivities.
Key players in the market
Some of the key players in Personalized Supplements Market include Nestle Health Science, Amway Corp., Herbalife Ltd., Glanbia plc, Abbott Laboratories, DSM-Firmenich AG, BASF SE, Persona Nutrition, Care/of, Rootine Inc., Nutrigenomix Inc., Viome Life Sciences, Inc., Baze Labs, Inc., Thorne HealthTech, Inc., Nature's Bounty Co., NOW Health Group, Inc., and Hum Nutrition Inc.
In March 2026, Herbalife announced a definitive agreement to acquire assets from Bioniq, a UK-based personalized supplements company. The $150 million deal (including performance-based contingencies) integrates Bioniq's patented personalization engine into Herbalife's global distributor network, utilizing blood biomarkers and health data to scale tailored nutrition for consumers and elite athletes like Cristiano Ronaldo.
In March 2026, dsm-firmenich announced the expansion of its "Longevity Experience" for Vitafoods Europe, debuting new science-backed ingredients targeting cellular hallmarks of aging and personalized gut-brain health.
In October 2025, BASF launched Lutavit(R) A/D3 1000/200 NXT, a next-generation microencapsulated vitamin formulation designed for high stability and bioavailability in customized feed and supplement applications.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.